Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 4:54 PM
Ignite Modification Date:
2025-12-24 @ 4:54 PM
NCT ID:
NCT00209950
Brief Summary:
To evaluate the safety and tolerability of gaboxadol in primary insomnia
Detailed Description:
To evaluate long-term safety of gaboxadol in healthy adults.
Study:
NCT00209950
Study Brief:
Protocol Section:
NCT00209950